Increase Cell Performance with Recombinant Human Albumin скачать в хорошем качестве

Increase Cell Performance with Recombinant Human Albumin

As a long-established ingredient of cell-culture media, albumin is well recognized for its ability to facilitate the growth of many cell types. The industry is now seeing its properties expanded for use in the cryopreservation and formulation of stem cell therapies. As part of this webinar, we look at the manufacturing, formulation and logistic challenges associated with the development of cell therapies and assess how the use of fully recombinant human albumin, especially the cryopreservation of stem cells, is demonstrating the new potential for the regenerative medicine field. The advance of stem cell therapies presents several development and formulation challenges. Product heterogeneity is one of the main concerns and is a function of the entire value chain design, from harvesting, upstream culture and cell preservation to cell therapy administration. Consequently, pharmaceutical companies are striving to understand and control all steps in order to increase cell viability and minimize variability. This webinar will discuss the use of recombinant human albumin in stem and immune cell therapies, with the following focus: Primary challenges faced by the cell therapy industry today Albumin in cell therapies: Properties of albumin and areas of application in cell therapy Recombinant albumin: What are the benefits of choosing a recombinant product Increasing cell viability during cryopreservation Use of albumin in isolating lymphocytes Stem cell therapy is a cutting-edge therapeutic field, but still young and with a lot of room for optimization to ensure they reach patients. Recombinant human albumin offers a safe solution for optimized cell performance. As an animal and human component-free product, it provides regulatory benefits while improving cell viability and controlling batch-to-batch consistency. In this webinar, we will share examples of how using an ultra-pure recombinant human albumin source in the downstream processing of cell therapies offers advantages along the entire value chain. Solving the processing and formulation challenges in the field of cell therapies is a daunting task; listen in on this webinar to learn more about how the use of recombinant human albumin may provide some of the answers and give you confidence in your cell therapy development.